Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-2-17
pubmed:abstractText
The orphan receptor LRH-1 and the oxysterol receptors LXRalpha and LXRbeta are established transcriptional regulators of lipid metabolism that appear to control inflammatory processes. Here, we investigate the anti-inflammatory actions of these nuclear receptors in the hepatic acute phase response (APR). We report that selective synthetic agonists induce SUMOylation-dependent recruitment of either LRH-1 or LXR to hepatic APR promoters and prevent the clearance of the N-CoR corepressor complex upon cytokine stimulation. Investigations of the APR in vivo, using LXR knockout mice, indicate that the anti-inflammatory actions of LXR agonists are triggered selectively by the LXRbeta subtype. We further find that hepatic APR responses in small ubiquitin-like modifier-1 (SUMO-1) knockout mice are increased, which is due in part to diminished LRH-1 action at APR promoters. Finally, we provide evidence that the metabolically important coregulator GPS2 functions as a hitherto unrecognized transrepression mediator of interactions between SUMOylated nuclear receptors and the N-CoR corepressor complex. Our study extends the knowledge of anti-inflammatory mechanisms and pathways directed by metabolic nuclear receptor-corepressor networks to the control of the hepatic APR, and implies alternative pharmacological strategies for the treatment of human metabolic diseases associated with inflammation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-11090131, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-11238557, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-11931768, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-12524534, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-15102878, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-15130581, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-15707893, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-15722558, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-15723037, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-15923626, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-16099381, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-16127449, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-16493426, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-16943422, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17110595, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17154495, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17158876, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17218271, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17244526, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17545995, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17657314, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17665897, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-17895379, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-18573887, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-18800767, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-19299558, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-19345186, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-19394292, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-19481530, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-19782030, http://linkedlifedata.com/resource/pubmed/commentcorrection/20159957-9971870
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1549-5477
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
381-95
pubmed:dateRevised
2010-9-28
pubmed:meshHeading
pubmed-meshheading:20159957-Acute-Phase Reaction, pubmed-meshheading:20159957-Animals, pubmed-meshheading:20159957-Anti-Inflammatory Agents, pubmed-meshheading:20159957-COS Cells, pubmed-meshheading:20159957-Cercopithecus aethiops, pubmed-meshheading:20159957-Female, pubmed-meshheading:20159957-Gene Expression Regulation, pubmed-meshheading:20159957-HeLa Cells, pubmed-meshheading:20159957-Humans, pubmed-meshheading:20159957-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:20159957-Liver, pubmed-meshheading:20159957-Mice, pubmed-meshheading:20159957-Mice, Inbred C57BL, pubmed-meshheading:20159957-Mice, Knockout, pubmed-meshheading:20159957-Orphan Nuclear Receptors, pubmed-meshheading:20159957-Receptors, Cytoplasmic and Nuclear, pubmed-meshheading:20159957-Small Ubiquitin-Related Modifier Proteins
pubmed:year
2010
pubmed:articleTitle
GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response.
pubmed:affiliation
Center for Biosciences, Department of Biosciences and Nutrition, Karolinska Institutet, S-14157 Huddinge/Stockholm, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't